| Greetings!
Join us for an exclusive online workshop on February 26, 2025, from 1:00 pm to 2:00 pm (EST), where industry experts will explore groundbreaking advancements in endotoxin testing. With the upcoming release of Chapter (86) to the United States Pharmacopeia (USP), this session will delve into the integration of non-animal-derived reagents, such as recombinant cascade (rCR) and recombinant Factor C (rFC), and their role in sustainable pharmaceutical quality control.
Led by Meg Provenzano, Product Manager at Veolia Water Technologies & Solutions, this workshop will provide a comprehensive case study comparing traditional Limulus Amebocyte Lysate (LAL) reagents with rCR technology. Participants will gain valuable insights into the efficacy, reliability, and practical applications of these innovative methods using the Sievers Eclipse Bacterial Endotoxins Testing (BET) Platform.
Ideal for pharmaceutical professionals, quality control specialists, laboratory managers, and regulatory affairs experts, this session will equip attendees with the knowledge to implement rCR technology in their endotoxin testing protocols while ensuring compliance with USP (86) guidelines. All participants will receive a certificate of attendance upon completion of the workshop.
Register now and be at the forefront of regulatory updates and sustainable testing methodologies. The registration deadline is February 19, 2025. | 
No comments:
Post a Comment